- Recommendation ID
- IPG518/1
- Question
- Current evidence on the safety and efficacy of implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes is limited in quality and quantity. Therefore the procedure should only be used in the context of research.
- Any explanatory notes
(if applicable) - Further research should give details of patient selection, including information about use of the procedure in patients with different levels of BMI. The research should provide information on complications; reasons for early removal of the device; medication used for treating type 2 diabetes, both when the device is in place and after its removal; and control of type 2 diabetes after device removal. NICE may update the guidance on publication of further evidence.
Source guidance details
- Comes from guidance
- Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes
- Number
- IPG518
- Date issued
- March 2015
Other details
Is this a recommendation for the use of a technology only in the context of research? | Yes |
Is it a recommendation that suggests collection of data or the establishment of a register? | No |
Last Reviewed | 23/04/2015 |